Urine Organic Acids as Metabolic Indicators for Global Developmental Delay/Intellectual Disability in Chinese Children

Objective: The purpose of this study was to search for differential metabolites in urine organic acids, and to characterize metabolic features that can be used to identify metabolites for exploration of global developmental delay (GDD)/intellectual disability (ID) etiology and pathogenesis. Methods: We screened positive test results that could explain GDD/ID from 1,253 cases, and the major differential metabolites in 132 urine organic acids from the 1,230 cases with negative results (863 GDD cases, 367 ID cases), and 100 typically developing children (TD). Non-supervisory principal component analysis and orthogonal partial least squares discriminant analysis were used to develop models to distinguish GDD/ID from TD children, and to detect major differential metabolites. Results: We get 23 positive results that could identify the cause of GDD/ID from 1253 cases diagnosed with GDD/ID. Among 1,230 negative results, we get the differential metabolites of the GDD group and the ID group had the same trend compared with the TD group. Twenty four differential metabolites were obtained from the GDD group, and 25 from the ID group (VIP > 1.0, p < 0.01). These differential metabolites were mainly related to the following pathways: the synthesis and degradation of ketone bodies, citrate cycle, alanine, aspartate and glutamate metabolism, pyrimidine metabolism, butanoate metabolism, pyruvate metabolism, fatty acid biosynthesis, valine, leucine and isoleucine degradation. Conclusion: The use of metabolomics research methods to detect urine organic acids of children with GDD/ID can discover differential metabolites, which might be valuable for future research on the etiology, pathogenesis, prognosis and possible interventions of GDD/ID. The significantly altered differential metabolites indicators could therefore be potential diagnostic biomarkers for GDD/ID.

[1]  C. Ferreira,et al.  Treatable inherited metabolic disorders causing intellectual disability: 2021 review and digital app , 2021, Orphanet Journal of Rare Diseases.

[2]  Yi Ting Lim,et al.  Neuroimaging Spectrum of Inherited Neurotransmitter Disorders , 2019, Neuropediatrics.

[3]  Qiao Chen,et al.  Urine Organic Acids as Potential Biomarkers for Autism-Spectrum Disorder in Chinese Children , 2019, Front. Cell. Neurosci..

[4]  P. Saftig,et al.  Lysosomal storage disorders – challenges, concepts and avenues for therapy: beyond rare diseases , 2019, Journal of Cell Science.

[5]  L. Ducharme-Crevier,et al.  Acute pediatric hyperammonemia: current diagnosis and management strategies , 2018, Hepatic medicine : evidence and research.

[6]  N. Ah Mew,et al.  Propionyl-CoA carboxylase - A review. , 2017, Molecular genetics and metabolism.

[7]  S. Bamji,et al.  Protein palmitoylation in the development and plasticity of neuronal connections , 2017, Current Opinion in Neurobiology.

[8]  L. Ribeiro,et al.  Methylmalonate Induces Inflammatory and Apoptotic Potential: A Link to Glial Activation and Neurological Dysfunction , 2017, Journal of neuropathology and experimental neurology.

[9]  S. Strack,et al.  Mitochondrial dynamics in neuronal injury, development and plasticity , 2017, Journal of Cell Science.

[10]  Xuegong Zhang,et al.  CNV analysis in Chinese children of mental retardation highlights a sex differentiation in parental contribution to de novo and inherited mutational burdens , 2016, Scientific Reports.

[11]  P. Chiurazzi,et al.  Advances in understanding – genetic basis of intellectual disability , 2016, F1000Research.

[12]  M. King,et al.  Unexplained developmental delay/learning disability: guidelines for best practice protocol for first line assessment and genetic/metabolic/radiological investigations , 2016, Irish Journal of Medical Science (1971 -).

[13]  Shangzhi Huang,et al.  Succinic semialdehyde dehydrogenase deficiency of four Chinese patients and prenatal diagnosis for three fetuses. , 2015, Gene.

[14]  G. Carvill,et al.  Next-Generation Sequencing in Intellectual Disability , 2015, Journal of Pediatric Genetics.

[15]  J. Moeschler,et al.  Comprehensive Evaluation of the Child With Intellectual Disability or Global Developmental Delays , 2014, Pediatrics.

[16]  G. Carvill,et al.  Copy number variants are frequent in genetic generalized epilepsy with intellectual disability , 2013, Neurology.

[17]  M. S. van der Knaap,et al.  Progress in understanding 2-hydroxyglutaric acidurias , 2012, Journal of Inherited Metabolic Disease.

[18]  Sylvia Stockler,et al.  Treatable inborn errors of metabolism causing intellectual disability: a systematic literature review. , 2012, Molecular genetics and metabolism.

[19]  Hans van Bokhoven,et al.  Genetic and epigenetic networks in intellectual disabilities. , 2011, Annual review of genetics.

[20]  C. Mathers,et al.  Prevalence of intellectual disability: a meta-analysis of population-based studies. , 2011, Research in developmental disabilities.

[21]  Nam-Kyung Yu,et al.  DNA methylation-mediated control of learning and memory , 2011, Molecular Brain.

[22]  M. Shevell Present Conceptualization of Early Childhood Neurodevelopmental Disabilities , 2010, Journal of child neurology.

[23]  M. Pineda,et al.  Mental retardation and inborn errors of metabolism , 2009, Journal of Inherited Metabolic Disease.

[24]  Albert Koulman,et al.  From differentiating metabolites to biomarkers , 2009, Analytical and bioanalytical chemistry.

[25]  P. Stankiewicz,et al.  Identification of chromosome abnormalities in subtelomeric regions by microarray analysis: A study of 5,380 cases , 2008, American journal of medical genetics. Part A.

[26]  G. Hoffmann,et al.  Pathophysiology, diagnosis, and treatment of methylmalonic aciduria—recent advances and new challenges , 2004, Pediatric Nephrology.

[27]  C. V. van Karnebeek [Inborn errors of metabolism are not hopeless; early identification of treatable conditions in children with intellectual disability]. , 2014, Nederlands tijdschrift voor geneeskunde.